Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tenofovir Alafenamide Fumarate”

52 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 52 results

Not applicableUnknownNCT04065230
What this trial is testing

Study of Tenofovir Alafenamide Fumarate Tablets (TAF) in Blocking Mother-to-child Transmission of Hepatitis B Virus

Who this might be right for
Hepatitis B VirusMother to Child Transmission
Southeast University, China 330
Large-scale testing (Phase 3)Study completedNCT02836249
What this trial is testing

Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Positive Hepatitis B (China)

Who this might be right for
HBVChronic HBV Infection
Gilead Sciences 181
Post-approval studies (Phase 4)UnknownNCT05122754
What this trial is testing

Switching From TDF-based Antiretroviral Therapy Regimens to B/F/TAF in Virally Suppressed Adults With HIV-1 Infection

Who this might be right for
HIV-1-infection
Shanghai Public Health Clinical Center 150
Not applicableUnknownNCT03640728
What this trial is testing

The Efficacy and Safety of Nucleos(t)Ide Analogues in the Treatment of HBV-related Acute-on-chronic Liver Failure

Who this might be right for
Hepatitis BVirus DiseasesLiver Failure
First Affiliated Hospital Xi'an Jiaotong University 200
Post-approval studies (Phase 4)Ended earlyNCT04665375
What this trial is testing

Can INSTI-associated Weight Gain be Halted or Reversed With a Switch to Doravirine/Lamivudine/Tenofovir DF?

Who this might be right for
HivWeight Gain
University Health Network, Toronto 4
Early research (Phase 1)Not Yet RecruitingNCT07295873
What this trial is testing

Drug-Drug Interaction Study Between Hydronidone and Entecavir, Tenofovir Disoproxil Fumarate, Tenofovir Alafenamide, and Tenofovir Amibufenamide

Who this might be right for
Chronic Hepatitis B Liver FibrosisDDI (Drug-Drug Interaction)
Beijing Continent Pharmaceutical Co, Ltd. 64
Large-scale testing (Phase 3)Study completedNCT02979613
What this trial is testing

Study to Evaluate Efficacy and Safety of Switching From TDF to TAF in Adults With Chronic Hepatitis B Who Are Virologically Suppressed

Who this might be right for
Chronic Hepatitis B
Gilead Sciences 490
Large-scale testing (Phase 3)Study completedNCT02836236
What this trial is testing

Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Negative Hepatitis B (China)

Who this might be right for
HBVChronic HBV Infection
Gilead Sciences 155
Not applicableLooking for participantsNCT06947356
What this trial is testing

Comparison of TAF and TDF in Preventing Mother-to-Child Transmission of HBV in Pregnancies With High Viral Loads

Who this might be right for
Hepatitis B
Guangzhou 8th People's Hospital 210
Large-scale testing (Phase 3)Study completedNCT03110380
What this trial is testing

Switching to a Fixed Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Adults Who Are Virologically Suppressed

Who this might be right for
HIV-1-infection
Gilead Sciences 567
Post-approval studies (Phase 4)Study completedNCT02771054
What this trial is testing

Tenofovir Alafenamide Fumarate (TAF) Effect on Residual Intrathecal Immune Activation

Who this might be right for
HIV
Göteborg University 22
Large-scale testing (Phase 3)Study completedNCT02269917
What this trial is testing

Study to Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Regimen Versus Boosted Protease Inhibitor (bPI) Along With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Regimen in Virologically-Suppressed, HIV-1 Infected Participants

Who this might be right for
Human Immunodeficiency Virus Type 1
Janssen R&D Ireland 1,149
Testing effectiveness (Phase 2)Study completedNCT03251144
What this trial is testing

Relative Mitochondrial Toxicity of Tenofovir Alafenamide (TAF) vs. Tenofovir Disoproxil Fumarate (TDF)

Who this might be right for
HIV/AIDSAntiviral ToxicityAntiviral Drug Adverse Reaction+1 more
University of California, Los Angeles 26
Post-approval studies (Phase 4)UnknownNCT04850950
What this trial is testing

Tenofovir Alafenamide to Prevent Perinatal Transmission of Hepatitis B

Who this might be right for
Chronic Hepatitis BMother-to-Child TransmissionSafety+3 more
The First Affiliated Hospital of Zhengzhou University 240
Early research (Phase 1)Study completedNCT03186482
What this trial is testing

RIFT: Effect of Rifampicin on Plasma PK of FTC, TAF and Intracellular TFV-DP & FTC-TP

Who this might be right for
HIV
St. Stephens Clinical Research 21
Large-scale testing (Phase 3)Study completedNCT01940341
What this trial is testing

Study to Compare Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF) in Participants With Chronic Hepatitis B Infection Who Are Negative for Hepatitis B e Antigen

Who this might be right for
HBeAg-negative Chronic Hepatitis B
Gilead Sciences 426
Not applicableStudy completedNCT03577470
What this trial is testing

An Italian Observation of Antiretroviral Treatment in Participants Taking Darunavir/ Cobicistat Plus Emtricitabine and Tenofovir Alafenamide Fumarate

Who this might be right for
Human Immunodeficiency Virus (HIV)
Janssen-Cilag S.p.A. 246
Large-scale testing (Phase 3)Study completedNCT02431247
What this trial is testing

Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Fixed Dose Combination (FDC) Versus a Regimen Consisting of Darunavir/Cobicistat FDC With Emtricitabine/Tenofovir Disoproxil Fumarate FDC in Treatment-naive HIV Type 1 Infected Subjects

Who this might be right for
Immunodeficiency Virus Type 1, Human
Janssen Sciences Ireland UC 725
Post-approval studies (Phase 4)Not Yet RecruitingNCT06221657
What this trial is testing

Clinical Trial for Non-inferiority and Safety of Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate in Patients With Hematologic Malignancies Who Require Prophylactic Hepatitis B Antiviral Treatment

Who this might be right for
Patients With Malignant Blood Disease Requiring Hepatitis B Antiviral Medication
Yonsei University 100
Testing effectiveness (Phase 2)Study completedNCT03115736
What this trial is testing

TAF for HIV-HBV With Renal Dysfunction

Who this might be right for
HIV and Hepatitis B Coinfection
Insel Gruppe AG, University Hospital Bern 24
Load More Results